| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | SVP &Pres, Neuromodulation
2 companies
Nanavaty Maulik is a SVP &Pres, Neuromodulation at BOSTON SCIENTIFIC CORP with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $8.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Director | Buy | 500 | $1.98 | $990.00 | New | +67.9% | +14.6% | ||
| May 28, 2021 | BSX Boston Scientific Corp | SVP &Pres, Neuromodulation | Sell | 78,192 | $42.59 | $3,330,439.68 | -31.9% | +5.0% | -3.2% | |
| Aug 28, 2020 | BSX Boston Scientific Corp | SVP &Pres, Neuromodulation | Sale+OE | 38,000 | $40.45 | $1,537,164.60 | -14.2% | - | - | |
| Mar 2, 2020 | BSX Boston Scientific Corp | SVP &Pres, Neuromodulation | Sale+OE | 16,763 | $37.47 | $628,183.37 | -6.1% | - | - |